BioSpace News Archive

An outpatient clinic or a department is one where patients can be treated for their illnesses without having the need to stay at the medical organization conventional outpatient clinics have provided treatment options for common ailments or medical issues that have a swift diagnosis and cure.

LipoMedix, a clinical-stage, oncology-focused pharmaceutical company involved in the development of innovative, safe and effective cancer therapy based on a pegylated liposomal drug delivery platform, today announced that its lead compound, Promitil® (PL-MLP)

All-in-one digital X-ray solution designed to streamline veterinarian’s workflow, while providing pets and their owners’ good health and peace of mind.

Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the BTIG MedTech and Digital Health Conference on Thursday, February 18, 2021 at 11:00 a.m. Eastern Time.

As COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

The largest provider of outpatient imaging services in the United States is significantly expanding its presence in Arizona through a new lease at Park Central in Phoenix.

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, announced that the underwriters of its public offering have exercised in full their option to purchase an additional 600,000 shares of common stock at the public offering price of $22.50 per share, less underwriting discounts and commissions.

One of the biggest challenges in drug development and personalized medicine is how to model the cellular microenvironment accurately

Cerner Corporation (Nasdaq: CERN) today announced results for the 2020 fourth quarter and full year that ended December 31, 2020.

Fluidigm Corporation, an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced that George Mason University in Fairfax, Va., is providing saliva-based COVID-19 testing using the Advanta™ Dx SARS-CoV-2 RT-PCR Assay on the Fluidigm® Biomark™ HD system.